A multicenter, phase 2 study to evaluate the efficacy and...

  • Main
  • 2020
  • A multicenter, phase 2 study to evaluate the efficacy and...
Endocrine Journal 2020

A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing’s syndrome other than Cushing’s disease

Tanaka, Tomoaki, Satoh, Fumitoshi, Ujihara, Makoto, Midorikawa, Sanae, Kaneko, Tomomi, Takeda, Tamami, Suzuki, Akina, Sato, Masahiko, Shimatsu, Akira
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Year:
2020
Journal:
Endocrine Journal
DOI:
10.1507/endocrj.EJ19-0617
File:
PDF, 2.23 MB
2020
Conversion to is in progress
Conversion to is failed